U.S. flag

An official website of the United States government

NM_000020.3(ACVRL1):c.289_294del (p.His97_Asn98del) AND Telangiectasia, hereditary hemorrhagic, type 2

Germline classification:
Pathogenic (1 submission)
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003236766.1

Allele description [Variation Report for NM_000020.3(ACVRL1):c.289_294del (p.His97_Asn98del)]

NM_000020.3(ACVRL1):c.289_294del (p.His97_Asn98del)

Gene:
ACVRL1:activin A receptor like type 1 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
12q13.13
Genomic location:
Preferred name:
NM_000020.3(ACVRL1):c.289_294del (p.His97_Asn98del)
Other names:
chr12-51913321 GCAACCA>G
HGVS:
  • NC_000012.12:g.51913326_51913331del
  • NG_009549.1:g.10909_10914del
  • NG_125717.1:g.104_109del
  • NM_000020.3:c.289_294delMANE SELECT
  • NM_001077401.2:c.289_294del
  • NM_001406487.1:c.289_294del
  • NM_001406488.1:c.289_294del
  • NM_001406489.1:c.289_294del
  • NM_001406490.1:c.289_294del
  • NM_001406491.1:c.289_294del
  • NM_001406492.1:c.289_294del
  • NM_001406493.1:c.289_294del
  • NM_001406494.1:c.289_294del
  • NM_001406495.1:c.61+791_61+796del
  • NP_000011.2:p.His97_Asn98del
  • NP_000011.2:p.His97_Asn98del
  • NP_001070869.1:p.His97_Asn98del
  • NP_001393416.1:p.His97_Asn98del
  • NP_001393417.1:p.His97_Asn98del
  • NP_001393418.1:p.His97_Asn98del
  • NP_001393419.1:p.His97_Asn98del
  • NP_001393420.1:p.His97_Asn98del
  • NP_001393421.1:p.His97_Asn98del
  • NP_001393422.1:p.His97_Asn98del
  • NP_001393423.1:p.His97_Asn98del
  • LRG_543t1:c.289_294del
  • LRG_543:g.10909_10914del
  • LRG_543p1:p.His97_Asn98del
  • NC_000012.11:g.52307110_52307115del
  • NM_000020.2:c.289_294delCACAAC
Molecular consequence:
  • NM_000020.3:c.289_294del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001077401.2:c.289_294del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001406487.1:c.289_294del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001406488.1:c.289_294del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001406489.1:c.289_294del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001406490.1:c.289_294del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001406491.1:c.289_294del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001406492.1:c.289_294del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001406493.1:c.289_294del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001406494.1:c.289_294del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001406495.1:c.61+791_61+796del - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Telangiectasia, hereditary hemorrhagic, type 2 (HHT2)
Synonyms:
Telangiectasia, hereditary hemorrhagic, type II; Osler Weber Rendu syndrome type 2
Identifiers:
MONDO: MONDO:0010880; MedGen: C1838163; Orphanet: 774; OMIM: 600376

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003935205HHT Research Lab - C. Olivieri, University Of Pavia
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenicinheritedresearch

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
Europeaninheritedyes6619not providednot providednot providedresearch

Citations

PubMed

Hereditary hemorrhagic telangiectasia: First demonstration of a founder effect in Italy; the ACVRL1 c.289_294del variant originated in the country of Bergamo 200 years ago.

Sbalchiero A, Abu Hweij Y, Mazza T, Buscarini E, Scotti C, Pagella F, Manfredi G, Matti E, Spinozzi G, Olivieri C.

Mol Genet Genomic Med. 2022 Aug;10(8):e1972. doi: 10.1002/mgg3.1972. Epub 2022 May 27.

PubMed [citation]
PMID:
35620871
PMCID:
PMC9356557

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From HHT Research Lab - C. Olivieri, University Of Pavia, SCV003935205.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1European66not providednot providedresearch PubMed (2)

Description

This in frame deletion variant in ACVRL1 was founded in 66 subjects showing clinical signs of HHT. Other 22 unaffected relatives were tested to test the effective co-segregation of the variant with the disease. These 88 individuals belong to 19 different families. For this variant was demonstrated an Italian Founder effect. PMID: 35620871

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1inheritedyesnot providednot providednot provided66not provided19not provided

Last Updated: Jul 1, 2023